Skip to main content

Table 3 Availability of malaria commodities and readiness for case management in the public sector, among all screened outlets

From: Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

  Public health facility Community health workers All public sector
N = 173 N = 430 N = 603
% (95% CI) % (95% CI) % (95% CI)
Diagnostics
 Any malaria blood testing 82.3 (74.9, 87.8) 87.2 (82.7, 90.6) 85.9 (82.1, 89.0)
 Malaria microscopy 27.8 (21.0, 35.8) 0.3 (0.1, 1.8) 7.2 (5.3, 9.7)
 RDT 81.7 (74.3, 87.4) 87.2 (82.7, 90.6) 85.8 (81.9, 88.9)
Anti-malarials
 Any first-line ACT (DHA PPQ and/or ASMQ FDC) 76.5 (67.8, 83.5) 74.1 (66.2, 80.7) 74.7 (68.3, 80.1)
 DHA PPQ 76.5 (67.8, 83.5) 74.1 (66.2, 80.7) 74.7 (68.3, 80.1)
 ASMQ FDC 0.0 (–) 0.0 (–) 0.0 (–)
 Primaquine 0.0 (–) 0.0 (–) 0.0 (–)
 Other non-artemisinin therapy 8.9 (4.9, 15.5) 0.0 (–) 2.2 (1.3, 3.9)
 IV/IM artesunate 0.0 (–) n/a 0.0 (–)
Readiness
 Availability of first-line ACT and malaria blood testing 75.9 (67.1, 82.9) 67.7 (60.2, 74.3) 69.7 (63.6, 75.1)
 Availability of first-line ACT, blood testing not available 0.7 (0.2, 2.4) 6.4 (4.1, 9.9) 5.0 (3.2, 7.6)